Proteasome subunit proteins and neuropathology in tauopathies and synucleinopathies: Consequences for proteomic analyses

Proteomics

Volumn 8, Issue 6, 2008, Pages 1221-1236

  Zouambia, Mohamed ^a   Fischer, David F ^b,f   Hobo, Barbara ^b   De Vos, Rob A I ^c   Hol, Elly M ^b   Varndell, Ian M ^d   Sheppard, Paul W ^d   Van Leeuwen, Fred W ^b,e  

^a UNIVERSITY OF SCIENCES AND TECHNOLOGY HOUARI BOUMEDIENE   (Algeria)

^b NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^c Laboratory for Pathology Oost Nederland   (Netherlands)

^d BIOMOL International LP   (United Kingdom)

^e MAASTRICHT UNIVERSITY   (Netherlands)

^f BioFocus DPI   (United Kingdom)

Author keywords

Alzheimer's disease; Lewy body disease; Multisystem atrophy; Pick's disease; Progressive supranuclear Palsy

Indexed keywords

ADENOSINE TRIPHOSPHATASE; PROTEASOME; PROTEIN SUBUNIT; SYNUCLEIN; TAU PROTEIN; UBIQUITIN;

ALZHEIMER DISEASE; ARTICLE; CINGULATE GYRUS; DIFFUSE LEWY BODY DISEASE; DOWN SYNDROME; ENTORHINAL CORTEX; FRONTOTEMPORAL DEMENTIA; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; NEUROCHEMISTRY; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PICK PRESENILE DEMENTIA; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; REAL TIME POLYMERASE CHAIN REACTION; SHY DRAGER SYNDROME; TAUOPATHY; TEMPORAL CORTEX;

ALZHEIMER DISEASE; ANTIBODIES; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; LEWY BODY DISEASE; MODELS, BIOLOGICAL; MULTIPLE SYSTEM ATROPHY; PICK DISEASE OF THE BRAIN; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN SUBUNITS; PROTEOMICS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SYNUCLEINS; TAUOPATHIES; TEMPORAL LOBE;

EID: 41549101387     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200700679     Document Type: Article

References (55)

1. Lowe, J., Blanchard, A., Morrell, K., Lennox, G. et al., Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson's disease, Pick's disease, and Alzheimer's disease, as well as Rosenthal fibres in cerebellar astrocytomas, cytoplasmic bodies in muscle, and Mallory bodies in alcoholic liver disease. J. Pathol. 1998, 155, 9-15.
2. Ciechanover, A., Brundin, P., The ubiquitin proteasome system in neurodegenerative diseases: Sometimes the chicken, sometimes the egg. Neuron 2003, 40, 427-466.
3. Bennett, E. J., Shaler, T. A., Woodman, B., Ryu, K. Y. et al., Global changes to the ubiquitin system in Huntington's disease. Nature 2007, 448, 704-708.
4. Mori, H., Kondo, J., Ihara, Y., Ubiquitin is a component of paired helical filaments in Alzheimer's disease. Science 1987, 235, 1641-1644.
5. Perry, G., Friedman, R., Shaw, G., Chau, V., Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites of Alzheimer disease brain. Proc. Natl. Acad. Sci. USA 1987, 84, 3033-3036.
6. Alves-Rodrigues, A., Gregori, L., Figueiredo-Pereira, M. E., Ubiquitin cellular inclusions and their role in neurodegeneration. Trends Neurosci. 1998, 21, 516-520.
7. Fergusson, J., Landon, M., Lowe, J., Dwson, S. et al., Pathological lesions of Alzheimer's disease and dementia with Lewy bodies brains exhibit immunoreactivity to an ATPase that is a regulatory subunit of the 26S proteasome. Neurosci. Lett. 1996, 219, 167-170.
8. Keller, J. N., Hanni, K. B., Markesbery, W. R., Impaired proteasome function in Alzheimer's disease. J. Neurochem. 2000, 75, 436-439.
9. Chai, Y., Koppenhafer, S. L., Shoesmith, S. J., Perez, M. K., Paulsaon, H. L., Evidence for proteasome involvement in polyglutamine disease: Localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro. Hum. Mol. Genet. 1999, 8, 673-682.
10. Schmidt, T., Lindenberg, K. S., Kres, S., Schöls, F. et al., Protein surveillance machinery in brains with spinocerebellar ataxia type 3: Redistribution and differential recuitment of 26S proteasome subunits and chaperons to neuronal intranuclear inclusions. Ann. Neurol. 2002, 51, 302-310.
11. Díaz-Hernández, M., Hernández, F., Martín-Aparicio, E., Martin-Aparicio, E. et al., Neuronal induction of the immuno-proteasome in Huntington's disease. J. Neurosci. 2003, 23, 11653-11661.
12. Braun, B. C., Glickman, M., Kraft, R., Dahlman, B. et al., The base of the proteasome regulatory particle exhibits chaperone-like activity. Nat. Cell Biol. 1999, 1, 221-226.
13. Köhler, A., Cascio, P., Leggett, D. S., Woo, K. M. et al., The axial channel of the proteasome core particle is gated by the Rpt2 ATPase and controls both substrate entry and product release. Mol. Cell 2000, 7, 1143-1152.
14. Young, P., Deveraux, Q., Beal, R. E., Pickart, C. M. et al., Characterization of two polyubiquitin binding sites in the 26 S protease subunit 5a. J. Biol. Chem. 1998, 273, 5461-5467.
15. Lam, Y. A., Lawson, T. G., Velayutham, M., Zweier, J. L., et al., A proteasomal ATPase subunit recognizes the polyubiquitin degradation signal. Nature 2002, 416, 763-767.
16. Sakata, E., Yamaguchi, Y., Kurimoto, E., Kikuchi, J. et al., Parkin binds the Rpn10 subunit of 26S proteasomes through its ubiquitin-like domain. EMBO Rep. 2003, 4, 301-306.
17. Verma, R., Aravind,.L., Oania, R., McDonald, W. H. et al., Role of RPN11 metalloprotease in deubiquitination and degradation by the 26S proteasome. Science 2002, 298, 611-615.
18. Ferrell, K., Wilkinson, C. R. M., Dubiel, W., Gordon, C., Regulatory subunit interactions of the 26S proteasome, a complex problem. TIBS 2000, 25, 83-88.
19. Pickart, C. M., Cohen, R. E., Proteasomes and their kin: Proteases in the machine age. Nat. Rev. Mol. Cell Biol. 2004, 5, 177-187.
20. Tanaka, K., Proteasomes: Structure and biology. J. Biochem. 1998, 123, 195-204.
21. Saigoh, K., Wang, Y. L., Suh, J. G., Yamanishi, T. et al., Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice. Nat. Genet. 1999, 25, 47-51.
22. Drews, O., Zong, C., Ping, P., Exploring proteasome complexes by proteomic approaches. Proteomics 2007, 7, 1047-1058.
23. Leroy, E., Boyer, R., Auburger, G., Leube, B. et al., The ubiquitin pathway in Parkinson's disease. Nature 1998, 395, 451-452.
24. Gong, B., Cao, Z., Zheng, P., Vitolo, V., Liu, S. et al., Ubiquitin hydrolase Uch-L1 rescues beta-amyloid-induced decreases in synaptic function and contextual memory. Cell 2006, 126, 775-788.
25. Kitada, T., Asakawa, S., Hattori, N., Matsumine, H. et al., Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998, 392, 605-608.
26. Dickey, C. A., Patterson, C., Dickson, D., Petrucelli, L., Brain CHIP: Removing the culprits in neurodegenerative disease. Trends Mol. Med. 2007, 13, 32-38.
27. Van Leeuwen, F. W., De Kleijn, D. P. V., Van den Hurk, W. H., Neubauer, A. et al., Frameshift mutants of amyloid precursor protein and ubiquitin-B are prominent in Alzheimer and Down patients. Science 1998, 279, 242-247.
28. Lindsten, K., De Vrij, F. M. S., Verhoef, L. G. G. C., Fischer, D. F. et al., Mutant ubiquitin found in neurodegenerative disorders is a ubiquitin fusion degradation substrate that blocks proteasomal degradation. J. Cell Biol. 2002, 157, 417-429.
29. Fischer, D. F., De Vos, R. A. I., Proper, E. A., Van Dijk, R. et al., Disease specific accumulation of mutant ubiquitin as a marker for proteasomal dysfunction in the brain. FASEB J. 2003, 17, 2014-2024.
30. De Pril, R., Fischer, D. F., Maat-Schieman, M. L. C., Hobo, B. et al., Accumulation of aberrant ubiquitin induces aggregate formation and cell death in polyglutamine diseases. Hum. Mol. Genet. 2004, 13, 1803-1813.
31. Song, S., Kim, S. Y., Hong, Y. M., Jo, D. G., Lee, J. Y. et al., Essential role of E2-25K/Hip-2 in mediating amyloid-beta neurotoxicity. Mol. Cell 2003, 12, 553-563.
32. De Pril, R., Fischer, D. F., Roos, R. A. C., Van Leeuwen, F. W. et al., Ubiquitin-conjugating enzyme E2-25k increases aggregate formation and cell death in polyglutamine diseases. Mol. Cell. Neurosci. 2007, 34, 10-19.
33. Jicha, G. A., Bowser, R., Kazam, I. G., Davies, P. et al., Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau. J. Neurosci. Res. 1997, 48, 128-132.
34. Dawson, S. P., Arnold, J. E., Mayer, N. J., Reynolds, S. E. et al., Developmental changes of the 26 S proteasome in abdominal intersegmental muscles of Manduca sexta during programmed cell death. J. Biol. Chem. 1995, 270, 1850-1858.
35. De Vos, R. A., Jansen, E. N., Stam, F. C., Ravid, R. R. et al., 'Lewy body disease': Clinico-pathological correlations in 18 consecutive cases of Parkinson's disease with and without dementia. Clin. Neurol. Neurosurg. 1995, 97, 13-22.
36. Ramakers, C., Ruijter, J. M., Deprez, R. H., Moorman, A. F. et al., Assumption-free analysis of quantitative real time polymerase chain reaction (PCR) data. Neurosci. Lett. 2003, 339, 62-66.
37. Hope, A. D., De Silva, R., Fischer, D. F., Hol. E. M. et al., Alzheimer's associated variant ubiquitin causes inhibition of the 26S proteasome and chaperone expression. J. Neurochem. 2003, 86, 394-404.
38. Lee, P. D., Sladek, R., Greenwood, C. M. T., Hudson, T. J., Control genes and variability: Absence of ubiquitous reference transcripts in diverse mammalian expression studies Genome Res. 2002, 12, 292-297.
39. Warrington, J. A., Nair, A., Mahadevappa, M., Tsyganskaya, M., Comparison of human adult and fetal expression and identification of 535 housekeeping/maintenance genes. Physiol. Genomics 2000, 2, 143-147.
40. Ohana, B., Moore, P. A., Ruben, S. M., Southgate, C. D., Green, M. R., The type I human immunodeficiency virus Tat binding protein is a transcriptional activator belonging to an additional family of evolutionarily conserved genes. Proc. Natl. Acad. Sci. USA 1993, 90, 138-142.
41. Dubiel, W., Ferrell, K., Rechsteiner, M., Tat-binding protein 7 is a subunit of the 26S protease. Biol. Chem. Hoppe-Seyler 1994, 375, 237-240.
42. Loring, J. F., Wen, X., Lee, J. M., Selhamer, J., Somogyi, R., A gene expression profile of Alzheimer's disease. DNA Cell Biol. 2001, 20, 683-695.
43. Baes, M., Gulick, T., Choi, H. S., Martinoli, M. G. et al., A new orphan member of the nuclear hormone receptor superfamily that interacts with a subset of retinoic acid response elements. Mol. Cell Biol. 1994, 14, 1544-1551.
44. Choi, H.S., Seol, W., Moore, D. D., A component of the 26S proteasome binds an orphan member of the nuclear hormone receptor superfamily. J. Steroid Biochem. Mol. Biol. 1996, 56, 23-30.
45. Dawson, S. P., Apcher, S., Mee, M., Higashitsuji, H. et al., Gankyrin is an ankyrin-repeat oncoprotein that interacts with CDK4 kinase and the S6 ATPase of the 26S proteasome. J. Biol. Chem. 2002, 277, 10893-10902.
46. Rezvani, K., Mee, M., Dawson, S., McIlhinney, J. et al., Proteasomal interactors control activities as diverse as the cell cycle and glutaminergic neurotransmission. Biochem. Soc. Trans. 2003, 31, 470-473.
47. Bingol, B., Schuman, E. M., Activity-dependent dynamics and sequestration of proteasomes in dendritic spines. Nature 2006, 441, 1144-1148.
48. Mason, G. G. F., Murray, R. Z., Pappin, D., Rivett, A. J., Phosphorylation of ATPase subunits of the 26S proteasome. FEBS Lett. 1998, 430, 269-274.
49. Satoh, K., Nishikawa, T., Yokosawa, H., Sawada, H., Phosphorylation of proteasome substrate by a protein kinase associated with the 26S proteasome is linked to the ATP-dependent proteolysis of the 26S proteasome. Biochem. Biophys. Res. Commun. 1995, 213, 7-14.
50. Snyder, H., Mensah, K., Theisler, C., Lee, J., Matouschek, A., Aggregated and monomeric α-synuclein bind to the S6′ proteasomal protein and inhibit proteasomal function. J. Biol. Chem. 2003, 278, 11753-11759.
51. Shimura, H., Schlossmacher, M. G., Hattori, N., Frosch, M. P. et al., Ubiquitination of a new form of alpha-synuclein by parkin from human brain: Implications for Parkinson's disease. Science 2001, 293, 263-269.
52. Keck, S., Nitsch, R., Grune, T., Ulrich, O., Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer's disease. J. Neurochem. 2003, 85, 115-122.
53. Kaletja, R. F., Shenk, T., Proteasome-dependent, ubiquitin-independent degradation of the Rb family of tumor suppressors by the human cytomegalovirus pp71 protein. PNAS 2003, 100, 3263-3268.
54. Rechsteiner, M., Hill, C. P., Mobilizing the proteolytic machine: Cell biological roles of proteasome activators and inhibitors. Trends Cell. Biol. 2005, 15, 27-33.
55. Lam, Y. A., Pickart, C. M., Alban, A., Landon, M. et al., Inhibition of the ubiquitin-proteasome system in Alzheimer's disease. PNAS 2000, 97, 9902-9906.